Read More...

Medical Oncology, Radiation Oncology And Nuclear Medicine

Medical Oncology, Radiation Oncology, Nuclear Medicine

Oncology services at ILBS provide evidence-based multidisciplinary diagnostic and therapeutic applications to patients with cancer. The emphasis is on gastrointestinal/hepatopancreaticobiliary malignancies and other related tumors like neuroendocrine tumors, GIST, and GI lymphoma. Consultation and treatment for other malignancies like urogenital, lung, lymphoma, leukemia, head and neck, breast, gynaecological and brain tumors is also available. While the treatment strategy is scientific and evidence-based, it is also individualized considering patient’s social and economic profiles. Palliative care is an essential component along-with the cancer-directed therapy. In view of the increasing number of cancer patients in ILBS, hospital based cancer registry has been initiated under the National Centre for Disease Informatics and Research, ICMR

Medical Oncology

The services include a 9-bedded chemotherapy daycare and a 3-bedded inpatient ward. The department provides screening, diagnosis and treatment for cancers the digestive and other systems. The list of gastrointestinal cancers include liver, gall bladder, bile duct, pancreas, esophagus, stomach, colon, rectum, anal canal etc. Other malignancies like lymphoma, leukemia, sarcoma, lung, kidney, breast cancers etc are also under the purview of the department. Evidence-based chemotherapy protocols as per standard guidelines are followed. Chemotherapy is administered with good supportive treatment and a tender loving nursing care. Targeted molecular therapy and immunotherapy is practiced as per scientific evidence.

Radiation Oncology

The services include a state-of-the-art linear accelerator forevidence-based treatment of cancers with external radiotherapy.The department is completely equipped with 4-D CT simulator, TPS, and mould room. Provisions for advanced technologies with IGRT, SBRT, SRS, VMAT, IMRT, and 3-DCRT are available. Management of all cancers requiring radiotherapy is under the scope of the department. Advanced treatment with SBRT for hepatopancreaticobiliary cancers is a special area of expertise at ILBS. Motion management with respiratory gating is available for precise targeting of tumors. Focused radiation delivery to tumor target with sparing of normal tissues is the intent of radiotherapy for providing best outcome and quality of life to cancer patients. Our team of well trained and experienced physicians, physicists, and technical staff work together for providing best care to patients.The department is also going to procure brachytherapy in near future.

Nuclear Medicine

The department has been recently established. With advancements in technology and research, management of various cancers are being increasingly directed at the molecular and cellular levels in the form of targeted therapies. The assessment of disease status and response rates are increasingly being relied upon functional and metabolic signatures over and above the morphological changes. The need for a more precise diagnosis/prognostication of diseases and personalized medicine has moved the entire world like never seen before. And ILBS is no exception. As a result, ILBS has established a dedicated Nuclear Medicine Department with a state-of-the-art 128-slice time-of-flight PET-CT. The uniqueness of PET-CT lies on its ability to noninvasively assess diseases at the metabolic and molecular levels. PET-CT has become operational since February 2018. Moreover, the institute is procuring a 16-slice state-of-the-art SPECT-CT machine. In addition, the department would also be equipped with a 4-bedded high dose Nuclear Medicine therapy ward for Peptide Receptor Radionuclide Therapy (PRRT) and other high dose Nuclear Medicine therapies. Subsequently, the institute is committed to deliver the services of a full-fledged Nuclear Medicine Department to the public for better diagnosis/prognostication of diseases and personalized medicine, both for clinical and academic/research purposes.

Services Rendered

Services 2017 2018
OPD consultation
Medical Oncology
Radiation Oncology

2233
NA

2725
460
Chemotherapy Daycare 893 1394
IPD 215 299
PET-CT NA 714
Radiotherapy
No. of Patients
No. of Radiation Treatments

NA
NA

72
1177

New services & facilities

Latest technology state-of-the-art 128-Slice Time-of-Flight PET-CT has become operational since February 2018.The department has started routine FDG PET-CT services which is utilized in a number of oncologic and non-oncologic conditions as highlighted in the table below:

Oncologic Indications

Non-oncologic Indications

  • Differentiation of benign and malignant lesions
  • Staging of malignant diseases
  • Response evaluation in malignant diseases
  • Restaging (or surveillance) of malignant diseases
  • Differentiation of tumor recurrence from treatment

related changes

  • Unknown primary malignancy
  • Metabolic biopsy
  • RT planning in malignant diseases
  • Grading/prognostication of tumors
  • Evaluation before liver transplantation
  • Neurooncology

Whole Body PET-CT

  • Vasculitis
  • Osteomyelitis
  • Orthopedic prosthesis infections
  • Sarcoidosis
  • Fever of unknown origin
  • Tuberculosis
  • Other infective/inflammatory conditions

Brain FDG PET-CT

  • Differential diagnosis of dementia;

mild cognitive impairment

  • Epilepsy
  • Movement disorders
  • Neurosarcoidosis

Cardiac FDG PET-CT

  • Evaluation of myocardial viability
  • Cardiac sarcoidosis

Distribution of various patients who underwent PET-CT are depicted in the chart below:

State-of-the-art advanced linear accelerator for treating cancers requiring radiotherapy made clinically functional in 2018. All techniques including SBRT, SRS, VMAT, IMRT, 3DCRT, Electron therapy are available.

Irradiation of blood products – Under development

Educational Activities

• Technical Training courses in biobanking- Under development

Course Offered

Course No. of seats
Post Doctoral Certificate Course in HPB/GI Oncology No. of seats - 2

Department’s Achievements

Research activity in the dept:

  • Hospital Based Cancer Registries – Data Management Software under National Centre for Disease Informatics and Research, Bengaluru

Visiting faculty to the department in 2018

  • Dr. Chandan Guha Vice-chair and Professor, Radiation Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, USA
 

Faculty

Copyright © Institute of Liver & Biliary Sciences 2019. All rights reserved. Application Development and Maintenance by Cyfuture